J&J to buy cancer drug technology developer Firefly Bio for $1 billion

Markets Investing.com By Reuters 08 Jun 2026 12:30 1 min read

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.